Cancer Research Articles

Four FCS physicians are the authors of five cancer research studies that will be presented at European Society of Medical Oncology 2021.

A panel of medical experts recently provided the latest updates about COVID-19 and fielded questions from local residents. COVID-19: Speaking from Science, presented by Florida Cancer Specialists & Research Institute (FCS) in partnership with the Leesburg Area Chamber of Commerce, the City of Leesburg and Red Apples Media was held on Saturday, Aug. 28.

FCS continues to expand the number and scope of clinical trial opportunities available to cancer patients in the community setting.

In a recent evaluation, empirical data indicates FCS decreased emergency room visits not resulting in an admission or observation stay by 18% and decreased inpatient hospital admissions by 15% from 2017 – 2020. 

FCS in partnership with the Leesburg Chamber of Commerce, City of Leesburg and Red Apples Media, is sponsoring a panel discussion with area physicians to provide the latest information about COVID-19.

A survey conducted found that patients overwhelmingly prefer that the FCS physicians, nurses and staff members are vaccinated and wear masks to reduce the spread of COVID-19.

In response to growing concerns amidst the statewide surge of COVID-19 variants, FCS will require all physicians and team members to be fully vaccinated by October 1, 2021.

The in-house oral oncolytic pharmacy of Florida Cancer Specialists & Research Institute (FCS), known as Rx To Go, has been accredited by the National Association of Boards of Pharmacy® (NABP®) for both specialty pharmacy and digital pharmacy practice.